Afqlir® is a biosimilar brand of aflibercept which was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 February 2026. Afqlir® is listed under the PBS General Schedule.
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection: